Overview
- 4 inspections across 4 sites are on record.
- 3 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2019-11-26.
At a glance
Inspections
4
Sites
4
Observations
3
Career since
Sep 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Wyeth Pharmaceutical Division of Wyeth Holdings LLC | 26 Nov 2019 | Biologics | On file |
| Merck Sharp & Dohme LLC | 20 Sep 2019 | Biologics | On file |
| Pfizer Ireland Pharmaceuticals Unlimited Company | 18 Sep 2018 | Biologics | On file |
| Sanofi Winthrop Industrie | 27 Sep 2017 | Biologics | On file |
Sites inspected
Wyeth Pharmaceutical Division of Wyeth Holdings LLCSanford, United States1 insp.
Merck Sharp & Dohme LLCWest Point, United States1 insp.
Pfizer Ireland Pharmaceuticals Unlimited CompanyDublin 22, Ireland1 insp.
Sanofi Winthrop IndustrieMarcy-L'Etoile, France1 insp.
Co-investigators
Investigators who share inspections with this person.
Anissa M Cheung2 shared
Prabhu P Raju2 shared
Jacqueline M Diaz Albert1 shared
Eileen A Liu1 shared
Christopher J Adams1 shared
Linda Thai1 shared
Brentley S Collins1 shared
Mihaly S Ligmond1 shared
Michele L Forster1 shared
Full investigator report
Get the verbatim findings behind Scott E Norris' 3 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site